Tissue-Engineered Products Provide New Options for Skin Coverage
Several types of tissue-engineered skin substitutes offer plastic surgeons new alternatives for skin coverage in patients with burns and other types of difficult-to-treat wounds, according to a special topic article in the December issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
"Skin substitutes have been a great advance for plastic surgery and provide several advances and options to heal wounds," write Dr. Dennis P. Orgill of Brigham and Women's Hospital, Boston, and colleagues. Their review introduces six categories of currently available tissue-engineered skin substitutes, while highlighting the need for more evidence on the appropriate use in specific situations.
New Options for Difficult Skin Coverage Problems
Providing adequate skin coverage for certain types of wounds—for example, major burns or non-healing skin ulcers—can be a major challenge in plastic and reconstructive surgery. Skin grafts can be used, but in some situations adequate skin donor tissue is simply not available.
Over the years, various tissue-engineered products have enabled new approaches to skin coverage in these difficult situations. "Better understanding of the skin architecture and its bioactive components has enabled the development of a wide range of skin substitutes," Dr. Orgill and coauthors write.
In their article, they provide plastic surgeons with an overview of the range of modern tissue-engineered skin substitutes. The options are categorized as:
Allografts. Products made of processed skin from human donor skin, which can be packaged for a long shelf-life. For example, one allograft product consists of decellularized skin, preserving the underlying structure and bioactive components to help stimulate wound healing.
Allogeneic skin equivalents. Artificially grown skin substitutes used to support regeneration of the patient's own tissues. These one- or two-layer products provide "living and functional cellular skin constructs" to help restore normal wound healing in chronic wounds.
Dermal templates. Semi-synthetic products are made of collagen—the major structural protein of the body's connective tissue. They provide a scaffold for ingrowth of normal cells, which repopulate and eventually replace the scaffold.
Epidermal replacement. "Epidermal equivalent" products cultured or expanded from the patient's own skin cells. These products are limited by their high cost and long culture time (three to four weeks), as well as the fragility of the resulting skin substitute.
Xenografts.Skin from other species processed for use as a skin substitute. For example, sterilized products prepared from pig skin are sometimes used for temporary wound coverage.
"Skin substitutes have been a great advance for plastic surgery and provide several advances and options to heal wounds," Dr. Orgill and coauthors write. They emphasize the need for further research evidence to help guide the most appropriate use of the various types of tissue-engineered skin products.
Dr. Orgill and colleagues also look forward to continued research and development leading to even more advanced skin substitutes for large or nonhealing wounds. They conclude, "Future developments including advances in scaffolds, stem cells, and tissue processing are likely to produce even more clinical options for our patients."
Plastic and Reconstructive Surgery® is published by Wolters Kluwer.
About Plastic and Reconstructive Surgery
For more than 70 years, Plastic and Reconstructive Surgery® has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair, and cosmetic surgery, as well as news on medico-legal issues.
The American Society of Plastic Surgeons (ASPS) is the world's largest organization of board-certified plastic surgeons. Representing more than 8,000 Member Surgeons, the Society is recognized as a leading authority and information source on aesthetic and reconstructive plastic surgery. ASPS comprises more than 93 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the Society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada. ASPS advances quality care to plastic surgery patients by encouraging high standards of training, ethics, physician practice and research in plastic surgery.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.